Certain SJM Pericardial Patches from Glycar SA may not meet the required tensile strength specification
Similar Posts
SCA Pharmaceuticals Inc. Little Rock, AR. 483 issued 10/30/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 10/30/2025
Short Title (70 char) SCA Pharmaceuticals Inc. Little Rock, AR. 483 issued 10/30/2025
FEI Number 3010683157
Firm Name SCA Pharmaceuticals Inc
Record Type 483
State AR
Establishment Type Outsourcing FaCondition-Specific Meeting Reports and Other Information Related to Patients’ Experience
This webpage provides links to certain publicly available external reports and resources relating to patient experience data. The patient community, patient advocates, researchers, drug developers, and federal agencies may find these materials useful.Conducting Remote Regulatory Assessments Questions and Answers
Conducting Remote Regulatory Assessments Questions and Answers Guidance for IndustryWhy Not Natural, Houston, Texas, is Recalling its Why Not Natural Organic Moringa – Green Superfood because of Possible Health Risk
Why Not Natural, Houston, Texas, is voluntarily recalling its Why Not Natural Organic Moringa – Green Superfood because they may be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened imRegulatory Pharmaceutical Fellowship Program
Explore the FDA’s Regulatory Pharmaceutical Fellowship Program, a partnership with academia and industry, offering specialized training in regulatory science, policy, and drug development. Learn how to advance your career in the pharmaceutical field through this unique fellowship opportunity.Guidance Snapshot Pilot
Guidance Snapshots are a communication tool that provide highlights from the document using visuals and plain language. This pilot program is intended to increase awareness for FDA guidance documents to support the efficient application of the documents’ recommendations.